McEwen Inc. 8-K

What Happened

• McEwen Inc. filed an 8-K disclosing the results of its annual meeting held June 4, 2026. Of 59,452,799 shares outstanding and entitled to vote, 34,079,421 shares (≈57.3%) were voted, establishing a quorum.
• Shareholders elected all eleven nominated directors, ratified Ernst & Young LLP (EY) as the independent registered public accounting firm for 2026, and approved the issuance of common stock to Robert R. McEwen as described in the proxy statement.
• Notable vote totals: director votes generally received about 25.4–26.3 million "For" votes; John Florek received 22,173,375 "For" and 4,316,758 "Withheld." EY ratification: 33,905,193 For, 129,269 Against, 44,959 Abstain. Issuance to Robert R. McEwen (votes by disinterested shareholders): 17,696,367 For, 278,311 Against, 96,004 Abstain; broker non‑votes 7,589,283.

Key Details

• Quorum: 34,079,421 shares voted (≈57.3% of 59,452,799 outstanding shares entitled to vote).
• Directors: All 11 nominees elected; most received ~26.2M For votes; highest withheld votes recorded for John Florek (4,316,758).
• Auditor ratification: EY approved with 33,905,193 For (small number opposed/abstained).
• Stock issuance approval: Disinterested shareholders voted 17,696,367 For (with 7,589,283 broker non‑votes affecting total shares present on that matter).

Why It Matters

• Governance: The board slate remains in place, which affects the company’s strategic and oversight continuity.
• Audit continuity: Ratifying EY maintains the company’s independent auditor for 2026, relevant to financial reporting and audit oversight.
• Share issuance: Approval to issue shares to Robert R. McEwen may affect future share count and ownership; investors should review the proxy statement for details on the number and terms of the issuance to assess potential dilution.